These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 12704005

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
    Gao KF, Liu FY, Chen FJ, Feng YL.
    Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic analysis of 88 patients with ovarian clear cell carcinoma].
    Ma SK, Zhang HT, Wu LY, Liu LY.
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):784-8. PubMed ID: 18396695
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimens.
    Roland PY, Barnes MN, Niwas S, Robertson MW, Alvarez R, Austin JM, Kilgore LC, Partridge EE.
    Gynecol Oncol; 1998 Feb; 68(2):178-82. PubMed ID: 9514799
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy of advanced ovarian cancer.
    Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F.
    Front Biosci; 1997 Mar 15; 2():g20-6. PubMed ID: 9159262
    [Abstract] [Full Text] [Related]

  • 9. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 15; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 10. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J.
    Acta Obstet Gynecol Scand; 2009 Mar 15; 88(4):463-7. PubMed ID: 19235559
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer].
    Yang D, Tong F, Cao Y, Liu P, Zhou B, Liu H, Qiao X, Zhang J.
    Zhonghua Zhong Liu Za Zhi; 2002 May 15; 24(3):303-5. PubMed ID: 12515634
    [Abstract] [Full Text] [Related]

  • 12. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug 15; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 13. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD, Zhang Q, Zhang Y.
    Ai Zheng; 2005 Aug 15; 24(8):1002-5. PubMed ID: 16086882
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
    Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE.
    Gynecol Oncol; 2007 Apr 15; 105(1):211-7. PubMed ID: 17239941
    [Abstract] [Full Text] [Related]

  • 16. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan 15; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 17. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS, Hacker NF, Lagasse LD, Poth T, Resnick B, Nieberg RK.
    Obstet Gynecol; 1984 Aug 15; 64(2):207-12. PubMed ID: 6539884
    [Abstract] [Full Text] [Related]

  • 18. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
    Lee SJ, Kim BG, Lee JW, Park CS, Lee JH, Bae DS.
    J Obstet Gynaecol Res; 2006 Feb 15; 32(1):99-106. PubMed ID: 16445534
    [Abstract] [Full Text] [Related]

  • 19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 15; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 20. [Multidisciplinary treatment of recurrent epithelial ovarian carcinoma and prognostic analysis].
    Huang X, Cai SM, Tang J, Li ZT, Zang RY.
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep 15; 39(9):602-5. PubMed ID: 15498187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.